Related Experiment Video
Updated: Feb 14, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Erythrocyte Aggregation and Blood Viscosity is Similar in Homozygous Sickle Cell Disease Patients with and without
Andre S A Bowers1, Walworth W Duncan2, D J Pepple1
1Physiology Section, Department of Basic Medical Sciences, University of the West Indies, Mona, Jamaica, West Indies.
Abstract:
Background There is no consensus regarding the role of red blood cell (RBC) aggregation in the pathogenesis of leg ulcers (LUs) in sickle cell disease (SCD). Objectives We sought to evaluate whether the cross-sectional determination of RBC aggregation and hematological indices were associated with the presence of LU in homozygous SCD. Methods Twenty-seven patients with LU and 23 with no history of ulceration were recruited into the study. A laser-assisted rotational red cell analyzer (LoRRca) was used in the determination of the aggregation index (AI), aggregation half-time ( t1/2 ), and the RBC aggregate strength (AMP). Hematological indices were determined using a CELL-DYN Ruby analyzer. Whole blood viscosity (WBV) and plasma viscosity (PV) were measured using a Vilastic bioprofiler. The data were presented as means ± standard deviation or median, interquartile range. Two-sample t -test was used to test for associations between the AIs, WBV, and PV in patients with and without LU. Statistical significance was taken as p < 0.05. All analyses were conducted using Stata/SE v . 12.1 (StataCorp, College Station, TX). Results The AI was comparable in the group with and without ulcers (68.6, 16.7 versus 67.7, 16.9; p = 0.74); t1/2 (1.7, 1.3 versus 1.8, 1.3; p = 0.71); AMP (18.8, 14.5 versus 19.1, 13.3; p = 0.84), WBV (3.8, 1.2 versus 3.8, 0.7; p = 0.77); and the PV (1.3, 0.08 versus 1.4, 0.1; p = 0.31) and were also not statistically different between the groups of participants. Conclusion RBC aggregation and aggregate strength are not associated with leg ulceration in SCD.
Related Concept Videos
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Assessing Blood pressure in the Leg
Preparation:
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Viscosity
The SI unit of viscosity is...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

